Free shipping on all orders over $ 500

 About 8 results found for searched term "100-10-7" (0.054 seconds)

Cat.No.  Name Target
M1898 Plerixafor (AMD3100) CXCR
AMD3100; JM3100; ID791; AMD-3329
Plerixafor (AMD3100) is a CXCR4 chemokine receptor antagonist.
M2727 GS-9256 HCV Protease
GS-9256 is a novel phosphinic acid derived inhibitor of the HCV NS3/4A protease with IC50 of 4 nM.
M11432 Razuprotafib Phosphatase
AKB-9778
Razuprotafib (AKB-9778) is an effective selective inhibitor of VE-PTP (HPTPß) catalytic activity (IC50=17 pM).
M6448 APcK 110 Others
APcK 110 is a kIT inhibitor.
M8037 Sutezolid Antibiotic
PNU-100480; U-100480; PF-02341272
Sutezolid (PNU-100480), an orally active oxazolidinone antimicrobial agent, acts by inhibiting bacterial protein synthesis. Sutezolid has potent activity against mycobacteria, and is used for the research of drug-resistant tuberculosis.
M24529 Sotatercept TGF-beta/Smad
ACE-011; MK-7962
Sotatercept (ACE-011; MK-7962) is a first-in-class activin receptor 2A (ACVR2A) type IgG Fc fusion protein. Sotatercept combines activin and growth differentiation factor to try to restore the balance between growth promotion and growth inhibition signal pathways. Sotatercept has potential application in pulmonary arterial hypertension, anemia, bone loss, erythropoiesis, multiple myeloma (MM) osteolytic lesions.
M24962 Semorinemab Others
RG 6100; RO7105705; MTAU-9937A
Semorinemab (RG 6100) is an anti-Tau humanized IgG4 monoclonal antibody, targets the N-terminal portion of the Tau protein (amino acid residues 6-23). Semorinemab binds with human Tau with a Kd value of 3.8 nM. Semorinemab can be used for the research of Alzheimer's Disease.
M39564 p-Dimethylaminobenzaldehyde Others
p-Dimethylaminobenzaldehyde (4-Dimethylaminobenzaldehyde) is an organic compound containing amine and aldehyde moieties which is used in Ehrlich's reagent and Kovac's reagent to test for indoles.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.